Facing Congressional Probe, Compounding Group Denies Helping Pharmacists Sidestep FDA

A bipartisan congressional inquiry into allegations an international compounding group helped pharmacies sidestep FDA oversight, a probe spurred by a recent New York Times article, prompted a vociferous denial Friday (Dec. 7) by the trade group, which said it would hand over internal documents that refute the article's conclusion.

Source found here.  Subscription required.